Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
V. Calancea (Chisinau, Republic of Moldova), T. Dumitras (Chisinau, Republic of Moldova), N. Ghicavii (Chisinau, Republic of Moldova), D. Barba (Chisinau, Republic of Moldova), D. Fetco-Mereuta (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova)
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Disease area: Airway diseases, Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Calancea (Chisinau, Republic of Moldova), T. Dumitras (Chisinau, Republic of Moldova), N. Ghicavii (Chisinau, Republic of Moldova), D. Barba (Chisinau, Republic of Moldova), D. Fetco-Mereuta (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova). Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension. 2469
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: